Existing drug shows promise treating most prevalent type of lung cancer
byUniversity of KentuckyCZT binds to SRC. A. CZT binding (dashed circle) to SRC. CZT binds near the C-terminal domain of SRC and may disrupt the inactive state by preventing phosphorylation on t
Updated on: January 10,2024
6

Existing drug shows promise treating most prevalent type of lung cancer
byUniversity of KentuckyCZT binds to SRC. A. CZT binding (dashed circle) to SRC. CZT binds near the C-terminal domain of SRC and may disrupt the inactive state by preventing phosphorylation on t
Updated on:January 10,2024
6
